Mir Acquisition Inc is categorized under Commercial Medical Research in Ann Arbor, MI and active since 2011.
Mir Acquisition Inc was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Thomas Ludlam at the company’s single location by writing to 800 Technology Drive, Ann Arbor, Michigan MI 48108 or by phoning (734) 821-1063. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mir Acquisition Inc |
Contact Person: | Thomas Ludlam |
Address: | 800 Technology Drive, Ann Arbor, Michigan 48108 |
Phone Number: | (734) 821-1063 |
Website Address: | molecularimaging.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Mir Acquisition Inc was started in 2011 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Thomas Ludlam for inquiries that concern Mir Acquisition Inc by calling the company number (734) 821-1063, as your correspondence is most welcome. Additionally, the physical location of the single location of Mir Acquisition Inc can be found at the coordinates 42.213146,-83.743391 as well as the street address 800 Technology Drive in Ann Arbor, Michigan 48108.
For its online presence, you may visit Mir Acquisition Inc’s website at molecularimaging.com and engage with its social media outlets through on Twitter and on Facebook.